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Membrane phospholipids typically contain fatty
acids (FAs) of 16 and 18 carbon atoms. This partic-
ular chain length is evolutionarily highly conserved
and presumably provides maximum stability and
dynamic properties to biological membranes in
response to nutritional or environmental cues. Here,
we show that the relative proportion of C16 versus
C18 FAs is regulated by the activity of acetyl-CoA
carboxylase (Acc1), the first and rate-limiting enzyme
of FA de novo synthesis. Acc1 activity is attenuated
by AMPK/Snf1-dependent phosphorylation, which
is required to maintain an appropriate acyl-chain
length distribution. Moreover, we find that the tran-
scriptional repressor Opi1 preferentially binds to
C16 over C18 phosphatidic acid (PA) species: thus,
C16-chain containing PA sequesters Opi1 more
effectively to the ER, enabling AMPK/Snf1 control of
PA acyl-chain length to determine the degree of dere-
pression of Opi1 target genes. These findings reveal
an unexpected regulatory link between the major en-
ergy-sensing kinase, membrane lipid composition,
and transcription.
INTRODUCTION
The biogenesis of biological membranes that delineate the cell
surface or act as intracellular space partition is a fundamental
biological process and a remarkable evolutionary achievement.
The hydrophobic barrier of membranes is comprised of fatty
acid (FA)-derived acyl-chains, typically 16 or 18 carbon atoms
in length; these FAs are synthesized in a cyclic series of reactions
by themultifunctional FA synthase (FAS) complex by the addition
of C2 units that are derived from malonyl-coenzyme A (CoA)Devel(Smith et al., 2003). Remarkably, the FA chain length in mem-
brane phospholipids (PLs) is evolutionarily highly conserved
(Daum et al., 1999; Schneiter et al., 1999; Alex Brown, 2012;
Han et al., 2012) and apparently provides maximum stability to
the otherwise fluid bilayer structure through their hydrophobic in-
teractions. At the same time, this acyl-chain composition permits
rapid and significant adjustments by a single elongation step
(C16/C18) and/or desaturation (C16:0/C16:1; C18:0/
C18:1) in response to alterations in environmental conditions
such as temperature. Furthermore, gradual increase in chain
length and, subsequently, membrane thickness along the secre-
tory pathway is an important determinant and provides sufficient
differentiation for protein sorting (Bretscher and Munro, 1993).
Similar to mammalian cells, yeast membranes predominantly
consist of mono- and di-unsaturated PLs containing C16 and
C18 acyl-chains to maintain the liquid crystalline state at physi-
ological temperature (de Kroon et al., 2013). A decrease in the
ambient temperature primarily triggers an increase in the C16/
C18 ratio rather than a change in the degree of acyl-chain desa-
turation (Martin et al., 2007).
The mechanisms that control the ratio between C16 versus
C18 FAs in cellular lipids are unknown. FAs are synthesized
de novo by the FAS complex, which typically limits acyl-chain
length extension to C16 and C18 carbon atoms, both in yeast
and in mammals (Okuyama et al., 1979; Wakil et al., 1983); FAs
are subsequently channeled through the common precursor
phosphatidic acid (PA) into the synthesis of neutral and polar
lipid species, i.e., storage triacylglycerols (TAG) and membrane
PLs, respectively. The substrate for the FAS complex, malonyl-
CoA, is synthesized by the multifunctional enzyme, acetyl-CoA
carboxylase (Acc1), the initial and rate-limiting step in cellular
FA de novo synthesis in yeast (Al-Feel et al., 1992; Chirala
et al., 1994; Hasslacher et al., 1993; Woods et al., 1994) and in
mammals (for a review, see Wakil and Abu-Elheiga, 2009).
Acc1 activity is tightly regulated at multiple levels. Nutritional
andmetabolic signals, such as glucose limitation and salt stress,
are transduced to Acc1 by the Snf1 kinase, the yeast ortholog of
mammalian AMP-activated protein kinase, AMPK (Carling et al.,opmental Cell 29, 729–739, June 23, 2014 ª2014 The Authors 729
Figure 1. Role of Acc1 in Lipid Metabolism
(A) Metabolic pathway for FA and lipid synthesis. Acc1, which is negatively
regulated by Snf1 kinase, catalyzes the rate-limiting step in FA de novo pro-
duction. The level of PA in the ER is responsible for transcriptional regulation of
many genes involved in PL synthesis, in particular INO1, by binding and
sequestering the repressor Opi1 at the nuclear ER.
(B) Schematic view of the yeast Acc1 protein (2,233 amino acids). The enzyme
consists of three domains: the biotin carboxylase domain (BC, amino acids
[aa] 58–567), the biotin-carboxyl carrier protein (BCCP, aa 701–767) and the
carboxyltransferase domain (CT, aa 1603–2101). The serine residue at position
1157 is the phosphorylation site for Snf1 kinase, which is located in an R/K-X-
X-S consensus motif that is present in many Snf1 substrates.
See also Figure S1.
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Acc1 Activity Regulates Gene Transcription1994; Hardie et al., 1998; Hedbacker and Carlson, 2008). Snf1 is
the major energy-sensing kinase that phosphorylates and inacti-
vates Acc1 in vivo under conditions of low energy load (Woods
et al., 1994). Thus, yeast mutants lacking Snf1 kinase display
3-fold elevated Acc1 activity; in addition, snf1mutants are defec-
tive in transcription of multiple genes including INO1, which
encodes inositol-3-phosphate synthase and represents the
most highly regulated gene of PL biosynthesis (Galdieri and
Vancura, 2012; Jesch et al., 2005; Santiago and Mamoun,
2003; Shirra et al., 2001). Inositol-3-phosphate synthase is
indispensable for the endogenous production of inositol, which
makes snf1 mutants dependent on inositol supplementation for
growth (Ino phenotype).
Notably, transcription of ACC1 and PL biosynthetic genes,
including INO1, is strongly regulated by inositol in the growthme-
dia, which is mediated by the UASINO element in the promoter of
these genes (Carman and Han, 2009; Henry et al., 2012, 2014).
Full activation of INO1 transcription occurs in the absence of
inositol and requires the Ino2/Ino4 transcriptional activator com-
plex that binds to the UASINO element (Ambroziak and Henry,
1994; Lopes and Henry, 1991). UASINO-containing genes are
repressed by Opi1 (White et al., 1991) by its interaction with
Ino2 in the nucleus (Wagner et al., 2001). Opi1 is a PA-binding
protein and shuttles between the endoplasmic reticulum (ER)
and the nucleus, dependent on the level of PA and the presence
of the yeast VAMP-associated protein (VAP) homolog Scs2, in
the ER. In the absence of inositol, PA levels are high, Opi1 is
bound to the ER, and transcription of INO1 is enabled, leading
to de novo production of inositol. In contrast, supplementation
of inositol to the growth medium depletes PA by draining it into
phosphatidylinositol (PI) synthesis, which promotes transloca-
tion of Opi1 into the nucleus and repression of the INO1 gene
(Loewen et al., 2004; Young et al., 2010). PA is a central lipid in-
termediate and precursor both for membrane PL and storage
TAG synthesis; however, it is currently unclear how the meta-
bolic flux either way is regulated in growing cells. Defects in PL
metabolism that lead to an increased steady-state concentration730 Developmental Cell 29, 729–739, June 23, 2014 ª2014 The Authof PA in the ER cause sequestration of the Opi1 repressor to the
ER and elevated transcription of UASINO-dependent genes. The
cho2 and opi3mutants, for instance, are defective in PL methyl-
ation and, thus, accumulate PA and overexpress INO1 leading to
overproduction and excretion of inositol into the growth medium
(Opi phenotype; Greenberg et al., 1982; McGraw and Henry,
1989; Summers et al., 1988).
We previously showed that the inositol requirement of the snf1
mutant is suppressed by downregulation of Acc1, suggesting
that its activity might be connected to the Ino2/Ino4/Opi1 regula-
tory circuit (Shirra et al., 2001). However, due to the pleiotropic
defects of the snf1 mutant, other regulatory mechanisms could
not be ruled out. For instance, lack of INO1 expression in the
snf1mutant was suggested to be a result of defective chromatin
modification (Lo et al., 2001). To uncouple Acc1 activity from
Snf1-dependent phosphorylation, we have now characterized
and mutated the specific phosphorylation site at position
serine 1157 of Acc1. We provide evidence for a direct regulatory
function of FA de novo synthesis in the transcriptional regulation
of PL biosynthesis through the Ino2/Ino4/Opi1 regulatory circuit.
We show that Acc1 activity is a critical determinant of the C16/
C18 acyl-chain ratio in cellular lipids; in conjunction with the
specific binding preference of the Opi1 repressor for C16-PA
species, this describes a regulatory mechanism of gene tran-
scription in response to altered acyl-chain length in cellular lipids
and unveils a function of the Snf1/AMP-activated protein kinase
in regulating lipid homeostasis.
RESULTS
Acc1 Is Phosphorylated by Snf1 Kinase at Serine 1157
Acc1 is one of the few direct enzymatic targets of Snf1 kinase. A
large-scale phosphoproteome analysis identified a single phos-
phorylation site at serine 1157 of Acc1 that is embedded in a
‘‘MNRAVSVSDLS’’ sequenceandmatches theAMPKconsensus
phosphorylation motif, R/K-X-X-S (Brinkworth et al., 2006; Dale
et al., 1995). Using avidin affinity-purified Acc1 protein, we char-
acterized and confirmed the phosphorylation site by qualitative
andquantitativemass spectrometry analyses (Figure 1; FigureS1
available online; see Supplemental Experimental Procedures for
a detailed description). In wild-type, about 63% of the Acc1 pro-
tein was phosphorylated at serine 1157, suggesting that the
majority of the enzyme is rather inactive in logarithmically growing
yeast cells. However, in snf1 cells, the phosphorylation level
at this residue in the Acc1 protein decreased by half to about
35%, confirming serine 1157 as the target site of Snf1 phos-
phorylation. Alternative phosphorylation of serine 1159, which
was recently predicted to be a potential phosphorylation site
(Oliveira et al., 2012), or phosphorylation of any other sites was
not detected in our phosphoproteome analyses of log-phase
yeast cells.
The acc1S/A Mutant Exhibits Inositol Auxotrophy and
TAG Accumulation
To assess its in vivo function, we mutated serine 1157 to an
alanine residue, thus locking the Acc1 enzyme in a nonphos-
phorylatable state. As shown in Figure 2A, the acc1S/A mutant,
generated in this fashion, grew like wild-type on complete yeast
extract peptone dextrose (YPD) media, but similarly to the snf1ors
Figure 2. Increased Acc1 Activity Leads to
Inositol Auxotrophy and Accumulation of
TAG and Lipid Droplets
(A) Growth of wild-type (WT), snf1, and acc1S/A
strains was monitored on rich media plates (YPD)
and inositol-containing (+I) or inositol-free (I)
media plates. Cells were spotted on to the indi-
cated media and grown for 2 days at 30C. The
concentration of Soraphen A (SorA) was 1 mg/ml.
(B–D) Cells were precultured logarithmically for
20 hr in +I medium.
(B) Visualization of lipid droplets with Bodipy in
cells grown logarithmically for 3 hr in fresh +I or I
medium. Scale bar, 5 mm.
(C) Total TAG levels were measured in cells grown
logarithmically for 3 hr on inositol-containing
(+I) medium and normalized to wild-type levels.
Results are presented as means ± SD; n = 3.
(D) Total FA content and composition was
measured in cells grown as in (C). Results are
presented as mean ± SD; n = 3.
See also Figure S2.
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A (SorA) (Shen et al., 2004; Vahlensieck et al., 1994). Increased
resistance to SorA indicates hyperactivity of Acc1 in these
strains. In addition, acc1S/A mutants, like the snf1 mutant strain,
were unable to grow on media lacking inositol (I medium). This
inositol auxotrophy (Ino phenotype) could be suppressed either
by decreasing Acc1 activity with SorA (Figure 2A) or in the snf1
mutant by downregulation of ACC1 transcription under control
of the heterologous doxycycline-repressible tet07 promoter
(tetO7-ACC1; Figure S2A). Yeast snf1 mutants were originally
identified by their inability to utilize exogenous sucrose (Snf,
sucrose nonfermenting phenotype), resulting from their failure
to express the SUC2 gene (encoding invertase) on glucose
depletion (Carlson et al., 1981). Notably, the acc1S/A mutant
was capable of growing on sucrose as the sole carbon source
or on nonfermentable carbon sources like glycerol or ethanol,
which distinguishes its phenotype from that of snf1 mutants
with respect to carbon source utilization (Figures S2B and
S2C). Acc1 hyperactivity in both snf1 and acc1S/A mutants leads
to highly elevated FA production and massive accumulation of
TAG and lipid droplets during logarithmic growth (Figures 2B
and 2C); these phenotypes are even more pronounced in sta-
tionary phase (Figure S2D). Most notably, as a result of elevated
malonyl-CoA production by hyperactive Acc1 in the acc1S/A
mutant, FA acyl-chain distribution was significantly shifted to-
ward longer acyl-chain lengths, increasing the C18:C16 acyl-
chain ratio from 0.5 in wild-type to 2.0 in the acc1S/A mutant
(Figure 2D). This shift is also reflected in the altered acyl-chain
composition of virtually all glycerolipid classes—for instance,
TAG (Figure S2E). Taken together, the acc1S/A mutant displaysDevelopmental Cell 29, 729–7similar phenotypes as the snf1 mutant
with respect to FA overproduction, a shift
to longer acyl-chains, and TAG accumu-
lation, as well as inositol auxotrophy.
Most notably, growth on nonferment-
able carbon sources clearly distinguishes
the acc1S/A mutant from the pleiotropicphenotypes that are associated with deletion of SNF1 and un-
couples Acc1 activity from other roles of Snf1 kinase in energy
and carbon metabolism.
Acc1 Activity Regulates Transcription of INO1
The observed growth defect of acc1S/A mutants on solid media
lacking inositol was reproduced in liquid cultures. When culti-
vated in the presence of inositol (+I medium), the acc1S/Amutant
grew at a rate identical to that of wild-type cells (Figure 3A; Fig-
ure S3A). After the shift to inositol-free medium, only a slightly
reduced growth rate of the acc1S/A mutant strain was observed
during the first 3 hr compared to wild-type, most likely due to
intracellular inositol pools that are consumed during that period
(Figure 3A; see also Figure S3B for detailed inositol titration
experiment). However, a dramatic increase in doubling time of
the acc1S/A mutant occurred between 3 and 6 hr after the shift
to inositol-free medium (Figure 3A). Notably, cells eventually
reached wild-type-like final cell density after 20 hr, suggesting
that cells are impaired in growth but remain viable (Figure S3A).
This reduced growth of the acc1S/A mutant in the absence of
inositol was cured by inhibition of Acc1 by SorA, clearly linking
the requirement for inositol supplementation to Acc1 activity.
Wild-type cells treated with the same concentration of SorA,
on the other hand, exhibited a severe growth defect in both the
presence and absence of inositol, which is consistent with the
essential role of Acc1 in cellular metabolism (Figure 3A).
We next asked whether the poor growth rate of the acc1S/A
mutant in the absence of exogenous inositol was indeed
associated with a reduced de novo production of that essential
metabolite, i.e., at the level of transcription of the INO1 gene.39, June 23, 2014 ª2014 The Authors 731
Figure 3. Inositol Auxotrophy of acc1S/A Is
Linked to the Ino2/Ino4/Opi1 Regulatory
Circuit
In each experiment, cells were precultured
logarithmically for 20 hr in inositol-containing (+I)
medium and shifted to freshmedium, as indicated.
The concentration of Soraphen A (SorA) was
1 mg/ml.
(A) Doubling times of wild-type and the acc1S/A
mutant between 0 and 3 and from 3 to 6 hr
of growth. Results are presented as mean ±
SD; n = 3.
(B) INO1 expression kinetics of wild-type and
acc1S/A strains were measured at indicated time
points, and values were normalized to wild-type
grown for 1.5 hr on medium containing inositol
(INO1-repressing conditions). ACT1 gene served
as internal control. Results are presented as
mean ± SD; n = 3.
(C) Cells were grown overnight in YPD medium at
30C and washed twice with sterile water. Five-
microliter aliquots of dilutions of OD600 = 1, 0.1,
0.01, and 0.001/ml were spotted on to the indi-
cated plates and incubated at 30C for 2 days.
[EV] – cells transformed with empty vector,
[INO1] – cells transformed with INO1 wild-type
gene under the regulation of the TEF1 promoter.
(D) Localization of Opi1-GFP fusion protein was
determined in wild-type and acc1S/A strains shif-
ted for 3 hr to inositol-free (I) medium in the
presence or absence of Soraphen A (SorA). Scale
bar, 2 mm.
See also Figure S3.
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3 hr following the shift to inositol-free medium; in contrast,
expression of INO1 was significantly attenuated in the acc1S/A
mutant strain. Consistent with the observed restoration of
growth in the absence of inositol, inhibition of Acc1 in the
acc1S/A mutant by SorA also restored wild-type-like INO1
expression kinetics (Figure 3B). These data support the notion
that lack of growth of the acc1S/A (and snf1) mutant on media
lacking inositol is linked to a defect in INO1 expression as a
consequence of Acc1 hyperactivity. Indeed, overexpression of
INO1 from a high-copy-number plasmid or deletion of the OPI1
gene fully restored growth of the acc1S/A strain in the absence
of inositol (Figure 3C and Figure S3C). In addition, downregula-
tion of ACC1 gene expression in the tetO7ACC1 strain by 0.5–
3.0 mg/ml doxycycline led to overproduction and secretion of
inositol (Opi phenotype; Figure S4A), clearly demonstrating
the inverse correlation between Acc1 activity and the ability to
express INO1 (Figure S4B). Full repression of ACC1 transcription
(>5.0 mg/ml doxycycline) led to cell death of the tetO7-ACC1
strain, further supporting the essential function of Acc1.
From previous studies, it is known that INO1 expression re-
sponds to the localization of Opi1, the transcription factor that
senses the levels of the central lipid intermediate, PA, in the ER
(Loewen et al., 2004). Consistent with the current model, Opi1-732 Developmental Cell 29, 729–739, June 23, 2014 ª2014 The Authorsgreen fluorescent protein (GFP) translo-
cated in wild-type cells from the nucleus
to the nuclear and peripheral ER within3 hr in inositol-free medium, leading to the observed rapid
INO1 induction. In marked contrast, the acc1S/A mutant retained
nuclear localization of Opi1-GFP after the shift to inositol-free
medium (Figure 3D); this defect in Opi1-GFP export from the nu-
cleus parallels the reduced INO1 expression kinetics. Notably,
inhibition of Acc1 activity in the acc1S/Amutant readily promoted
export of Opi1-GFP from the nucleus, leading to the observed
relief of INO1 expression (Figures 3B and 3D). Taken together,
these analyses demonstrate that this growth deficit of the
acc1S/A mutant is due to impaired INO1 expression through
the Ino2/Ino4/Opi1 regulatory circuit.
Since Opi1 localization responds to the amount of PA in the ER
(Loewen et al., 2004), we hypothesized that overproduction of
FA might lead to reduced cellular PA levels, perhaps due to its
increased channeling into TAG synthesis. This, however, was
not the case: analysis of the lipid profile in the acc1S/A mutant
showed that total glycerophospholipid content remained almost
unaltered compared to wild-type. Diacylglycerol (DAG) and TAG
levels were raised about 3- to 4-fold, which was reversed by
SorA treatment within 4.5 hr (Figure 4). Thus, elevated de novo
synthesized FAs are preferentially channeled into TAG synthesis,
without affecting total PL content. This observation is surprising
since both pathways share the common intermediate, PA. We
next analyzed to what extent cellular PA content was altered
Figure 4. Modulation of Acc1 Activity Affects Neutral Lipid Levels
but Renders Membrane PL Content Unaltered
Cells were precultured logarithmically for 20 hr in inositol-containing (+I)
medium and shifted to medium lacking inositol (I). The concentration of
Soraphen A (SorA) was 1 mg/ml. Total lipid content and composition were
analyzed at indicated time points. Lipid amounts were normalized to an
internal standard (IS) as described in the Experimental Procedures. PS,
phosphatidylserine; PE, phosphatidylethanolamine. Results are presented as
mean ± SD; n = 3.
See also Figure S4.
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Develas a result of hyperactive Acc1 in the acc1S/A mutant. Surpris-
ingly, the total PA pool was not decreased but rather slightly
increased compared to wild-type (Figure 5). This finding is incon-
sistent with the proposed mechanism by Loewen et al., that
reduced PA levels are responsible for translocation of Opi1
from the ER into the nucleus to repress Ino2/Ino4-dependent
INO1 transcription (Loewen et al., 2004). Since the molecular
species distribution in all glycerolipids displayed a characteristic
shift toward increased acyl-chain length in acc1S/A, we hypothe-
sized that not the total amount of PA but rather its specific mo-
lecular acyl-chain composition may define its binding affinity to
Opi1. Thus, we next analyzed the molecular species composi-
tion of PA (and of the major cellular PL phosphatidylcholine
[PC] as a reference) in wild-type and acc1S/A strains in greater
detail. As shown in Figure 5, PA 32:1 (containing C16:0 and
C16:1 acyl-chains) and PA 32:2 (containing two C16:1 acyl-
chains) species were indeed greatly reduced in the acc1S/A
mutant, whereas PA 36:1 (containing C18:0 and C18:1 acyl-
chains) and PA 36:2 (containing two C18:1 acyl-chains) species
were increased. This shift in acyl-chain composition was
reversed by the addition of SorA, a condition that also led to
inositol prototrophy (Figures 2A and 3A), derepression of INO1
(Figure 3B), and nuclear export of Opi1-GFP (Figure 3D) in the
acc1S/A strain.
Oleic Acid Supplementation Induces Inositol
Auxotrophy in Wild-Type and ole1 Strains
Based on the hypothesis that an increase in the proportion of
C18 versus C16 acyl-chains in PA is responsible for nuclear
localization of Opi1, we next tested whether exogenous C18:1
supply and concomitant changes in the acyl-chain composition
would phenocopy the effects of the hyperactive acc1S/A allele
also in wild-type cells. As shown in Figure 6A, addition of
C18:1 indeed induced inositol auxotrophy in wild-type cells.
This phenotype was not observed in the presence of palmitoleic
acid (C16:1) and, thus, cannot be due to a general ‘‘lipotoxic’’
effect of supplied FA on inositol-free media. Similarly, the ole1
mutant, which lacks the sole FA desaturase in yeast (Stukey
et al., 1989), and which is dependent on unsaturated FA supple-
mentation, displayed a strict inositol auxotrophy in the presence
of C18:1. Notably, growth of wild-type, ole1, and acc1S/A strains
on media lacking inositol was fully rescued by (co)supplementa-
tion with C16:1, indicating that this FA reversed the inositol
auxotrophy induced by excess C18:1 FA. This rescue of the
acc1S/Amutant growthwas not due to repression of Acc1 activity
by C16:1, since total C18 FAs remained at a high level, charac-
teristic for Acc1 hyperactivity; rather, the ratio between C16
and C18 FAs was restored by C16:1 supplementation (Fig-
ure 6B). The analysis of PA species in wild-type and ole1 strains
supplemented with C18:1 showed a similar shift toward longer
acyl-chain lengths as in the acc1S/A strain as compared to
wild-type grown without C18:1 (Figure 6C): PA 32:1 and PA
32:2 species were significantly decreased, whereas PA species
with longer FA chain length increased, especially 36:2.
The Opi1 Repressor Preferentially Binds Shorter-Chain
and More-Saturated PA Species
To further confirm whether the acyl-chain composition of PA
affects the interaction with Opi1, we performed in vitro bindingopmental Cell 29, 729–739, June 23, 2014 ª2014 The Authors 733
Figure 5. Acc1 Hyperactivity Affects Acyl-
Chain Composition of PL Classes
Cells were precultured logarithmically for 20 hr in
inositol-containing (+I) medium. Total content and
species composition of PC and PA were deter-
mined in cells shifted for 3 hr to fresh inositol-free
(I) medium with or without SorA (1 mg/ml) sup-
plementation. Lipid amounts were normalized
to an internal standard (IS) as described in the
Experimental Procedures. Results are presented
as mean ± SD; n = 3.
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of different PA species. Indeed and in line with our hypothesis,
we found significantly different binding affinities of Opi1 for PA
species dependent on the acyl-chain composition. Liposomes
containing saturated PA species (PA 32:0 and PA 36:0) showed
the highest affinity, followed by liposomes containing 32:1 PA;
liposomes containing PA 36:2 showed the lowest binding affinity
for purified Opi1. Liposomes, which consisted solely of PC 36:2,
showed no Opi1 binding at all (Figure 7). These results clearly
demonstrate that the acyl-chain composition of PA is a major
determinant of its interaction with the transcriptional repressor
Opi1. This preferred binding affinity explains the observed
phenotypes and significantly extends the current model of the
transcriptional regulation of PL biosynthesis in yeast in response
to deregulated FA de novo synthesis.
DISCUSSION
Throughout the eukaryotic kingdom, FAs of 16 or 18 carbon
atoms in length are the preferred acyl components in all glycero-
lipids that serve as bulk lipids in biological membranes or as
storage lipids. Whereas mechanisms controlling the level of FA
desaturation in response to ambient temperature andmembrane
fluidity have been described in detail, much less is known about
the mechanisms regulating chain length distribution (de Kroon
et al., 2013). In addition to their fundamental roles as components
of biological membranes, FAs also serve essential functions as
energy substrates, signaling molecules, or protein modifiers.
Cellular FA synthesis is also coordinated with nutritional supply,
activation, and incorporation into complex lipids to support
proper cell function and to prevent potentially detrimental FA-
induced lipotoxic effects, which are believed to be causative for
lipid-associated disorders, such as obesity and type 2 diabetes
in humans (KimandYe, 2013;Unger, 2002; Vidal-Puig andUnger,
2010). Thus, endogenousdenovosynthesis of particular FAsalso
plays an important role to counterbalance the physiological
impact of nutritional FAs that may be incorporated into cellular
lipids. According to their central role in cellular lipid synthesis,
both Acc1 and FAS have emerged as potential drug targets in
obesity-related diseases, as well as in cancer, which are charac-
terized by deregulated FA and lipid metabolism (Wakil and Abu-734 Developmental Cell 29, 729–739, June 23, 2014 ª2014 The AuthorsElheiga, 2009; Furuta et al., 2010; Pandey
et al., 2012; Wang et al., 2010; Liu et al.,
2010; Natter and Kohlwein, 2013).
In yeast and mammalian cells, acyl-
chain length is largely determined by theFAS complex that limits acyl-chain length to 16 and 18 carbon
atoms (Okuyama et al., 1979). We now show that the activity of
Acc1, the initial and rate-limiting enzyme of de novo FA synthe-
sis, is amajor determinant of total cellular FA production and also
has a fundamental impact on the relative distribution of C16 and
C18 acyl-chains in cellular lipids. Overproduction of FAs leads to
the accumulation of TAG and proliferation of cytosolic lipid drop-
lets, whereas membrane PL content remains unaltered. On the
other hand, the shift in acyl-chains toward longer residues is
reflected in all cellular glycerolipids, with consequences for the
binding and sequestration of the transcriptional repressor Opi1
to the ER.
The synthesis of FAs is a major energy- and carbon-
consuming pathway and, therefore, under several levels of con-
trol. One level involves the expression of theACC1 gene, which is
coordinately regulated with PL synthesis by the PL precursors,
inositol and choline, and the positive and negative transcription
factors Ino2/Ino4 and Opi1, respectively (Hasslacher et al.,
1993; Henry et al., 2012). The regulation of ACC1 expression
in coordination with PL biosynthetic genes (for review, see Teh-
livets et al., 2007) suggests that FA production must also be
balanced with TAG formation in growing cells in order to sustain
requirements for PL and membrane biogenesis. In addition, the
activity of Acc1 is strongly regulated by Snf1-dependent phos-
phorylation (Mitchelhill et al., 1994; Woods et al., 1994), which,
in turn, depends on the energy status of the cell (Wilson et al.,
1996).
Here, we made use of a yeast mutant that lacks the single
Snf1 phosphorylation site in Acc1 at serine 1157 (acc1S/A) and
exhibits phenotypes very similar to snf1 mutants with respect
to TAG and lipid droplet accumulation as well as inositol auxot-
rophy, demonstrating that these snf1 phenotypes are caused
by Acc1 hyperactivity. The evidence we present here strongly
supports the hypothesis that the inositol-requiring phenotype
of the acc1S/A strain is due to decreased INO1 expression that
is controlled by the well-characterized Ino2/Ino4/Opi1regulatory
circuit (Henry et al., 2012; Loewen et al., 2004), as both deletion
of OPI1, which uncouples transcriptional repression of INO1
from cellular PA levels, and overexpression of INO1 fully restored
inositol prototrophy to the acc1S/A mutant strain. We further
suggest that PL synthesis may be limited by the coordinated
Figure 6. Impact of FA Supplementation on
Inositol Auxotrophy
(A) Growth of wild-type, acc1S/A, and ole1 strains
was monitored on media plates with (+I) or without
(I) inositol plus indicted FAs. Oleic acid (C18:1)
and palmitoleic acid (C16:1) were dissolved in
tergitol and supplemented as indicated. The final
concentration of tergitol was 1%. Dilution series of
cells were spotted on to the indicated plates and
grown for 2 days at 30C.
(B) Effect of C16:1 supplementation on the FA
composition of wild-type and acc1S/A strains. Cells
were precultured logarithmically for 20 hr in +I
medium. FA content was measured after growing
cells for 3 hr in fresh +I medium with or without
0.05% C16:1 supplementation. The final concen-
tration of tergitol was 1%. Results are presented as
mean ± SD; n = 3.
(C) Impact of C18:1 supplementation on PA spe-
cies composition. Cells were precultured logarith-
mically for 20 hr in MES-buffered +I medium with
0.01% C18:1. PA species were measured after
growing cells for 6 hr in MES-buffered I medium
with or without 0.01%C18:1 supplementation. The
final concentration of tergitol was 1%. Results are
presented as mean ± SD; n = 3.
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in the presence of excess FA. The observed Opi1 transloca-
tion to the nucleus concomitantly slows cell growth as PL and
inositol production become limiting due to PA diversion into
TAG accumulation. Most notably, neither increased endogenous
FA production nor exogenous FA supply led to increased PL
accumulation, despite the fact that an altered acyl-chain compo-
sition is reflected in all PL classes; instead, excess FAs are pref-
erentially channeled into TAG. In addition, the similarity of the
cellular response to these two situations suggests that functional
TAG synthesis is crucial for accommodating these FAs, thus
avoiding the buildup of potential signal molecules, such as PA
or DAG, or free FAs (Garbarino and Sturley, 2009; Kohlwein,
2010; Kohlwein and Petschnigg, 2007; Petschnigg et al., 2009;
Fakas et al., 2011).
Importantly, our evidence significantly extends the current
model that indeed the acyl-chain composition of PA is the critical
determinant of Opi1 sequestration to the ER. We show that
alterations in the acyl-chain composition of the acc1S/A strainDevelopmental Cell 29, 729–7or of wild-type and the ole1 mutant in
the presence of oleic acid lead to inositol
auxotrophy due to the reduced binding
affinity of the Opi1 repressor to PA
molecular species containing longer acyl
residues. We hypothesize that the recog-
nition of the negatively charged head
group of PA by the basic tract of Opi1
might only represent the first level of
interaction, whereas the second level is
presumably determined by sensing the
nature of the acyl-chains of PA within
the ER membrane. Several other studies
also support the importance of acyl-chaincomposition of PA for interaction with proteins (Kooijman and
Burger, 2009); for example, the binding specificity of human
protein phosphatase 1 (PP1cg) to PA species harboring a higher
degree of acyl-chain unsaturation (Jones and Hannun, 2002).
However, no consensus sequence motif for PA binding proteins
has been identified yet (Stace and Ktistakis, 2006). It should be
noted that the acidic PLs PA and PI are exceptional regarding
their membrane activity compared to other PLs with respect to
impact on membrane packing, electrostatics, and membrane
curvature (Bigay and Antonny, 2012). PA is the only anionic PL
with a pronounced cone shape, facilitating protein penetration
into the membrane bilayer and recognition of the acyl moieties
(Kooijman et al., 2007; Shin and Loewen, 2011).
The actual concentration of PA in the yeast ER membrane is
not well defined. Previous studies reported PA levels between
0.5% and 3% of total PLs in isolated microsomal fractions
(Zinser et al., 1991; Pichler et al., 2001), whereas a recent
shotgun lipidomics study found about 10% PA of total lipids in
whole cell extracts (Klose et al., 2012). These findings indicate39, June 23, 2014 ª2014 The Authors 735
Figure 7. Opi1 Shows Preferred Binding
toward Shorter-Chain and More-Saturated
PA Species
Binding assays were performed with purified
GST-tagged Opi1 toward different PA species
embedded in liposomes consisting of 80 mol% di-
oleoyl-PC (PC 36:2) and 20 mol% PA as indicated
(left panel). Pellets represent the bound GST-Opi1
fraction and the supernatants represent the unbound GST-Opi1 fraction. An identical aliquot of GST-Opi1 as for the binding assays was used as loading control
(100% input), and a liposome consisting solely of PC 36:2 served as negative control for Opi1 binding (right panel). The western blot shows a representative result
of three independent experiments.
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cell fractionation and may indeed be present in higher amounts
than previously suggested. On the other hand, sole variation of
the acyl-chain composition of PA in the liposome binding assay
eliminated influences of membrane electrostatics and curvature
as well as of proteins, such as the yeast VAP Scs2, which is
required for binding of Opi1 to PA in vivo (Loewen et al., 2004).
The results obtained in this study have a number of implica-
tions. (1)Currently, themechanisms that regulate the total amount
of cellular PLs and their specific acyl-chain composition in
response to altered FA supply are largely unclear. A mechanism,
as described here, that responds not only to the content of critical
lipid intermediates such as PA but also to its specific molecular
composition provides an attractive regulatory circuit to integrate
metabolic input parameters, suchasavailability of nutritional FAs.
(2) FA synthesis itself is under several levels of control and has a
profound impact on metabolic and transcriptional regulation. (3)
The major and highly conserved energy-sensing Snf1 kinase op-
erates through additional levels of regulation, namely, its meta-
bolic downstream target Acc1. In conclusion, we demonstrate
that Acc1 hyperactivity leads to overproduction of FAs and a shift
in acyl-chain length distribution toward longer chains in all PL
classes aswell as in TAG. The acyl-chain distribution of PA is crit-
ical for its interaction with the Opi1 repressor, which displays
reduced affinity for PA molecular species containing longer and
more unsaturated acyl-chains. In the context of the snf1 mutant
scenario, Acc1 hyperactivity is a potent player in sequestering
carbon into fat production and regulating cell growth and prolifer-
ation. This unveils an impact of the major energy-sensing kinase
on membrane lipid composition and function and may explain
some of the seemingly unrelated pleiotropic consequences of
its deficiency.
EXPERIMENTAL PROCEDURES
Strains and Media
S. cerevisiae strains used in this study, except for the AID strain, are congenic
with BY, a derivative of S288C, and are listed in the Supplemental Experi-
mental Procedures. For liquid media experiments, cells were cultivated on a
rotary shaker at 30C and 180 rpm using threonine-free minimal synthetic
defined media with (+I) or without (I) 75 mM inositol (Villa-Garcı´a et al.,
2011). Solid YPD (1% yeast extract, 2% peptone and 2% glucose, 2% agar)
and yeast extract peptone (1% yeast extract, 2% peptone, 2% agar) with
2% of the nonfermentable carbon sources sucrose, glycerol, ethanol, or 1%
glycerol and 1% ethanol were additionally used for plate tests.
Culture Conditions and Calculation of Doubling Times
Cell cultivation—if not described differently—was performed as follows; a sin-
gle colony of the desired strainswas taken fromaYPDplate andgrown for 16 hr
in +I medium (50 ml) to midlogarithmic growth phase, rediluted to optical den-736 Developmental Cell 29, 729–739, June 23, 2014 ª2014 The Authsity 600 (OD600) = 0.1/ml in 100 ml of fresh +I medium, and grown for an addi-
tional 4.5 hr maintaining midlogarithmical growth. A cell aliquot of OD600 = 20
was then shifted by filtration (pore size, 0.45 mm) to 40ml of fresh +I andI me-
dia, respectively, resulting in an initial OD600 = 0.5/ml (0 hr time point). Cell
growth was monitored during growth, and doubling times were determined
from the OD600 readings as described elsewhere (Gaspar et al., 2011).
For cultivation of the FA auxotrophic ole1 strain, the media for the 16 hr pre-
cultivation and the 4.5 hr growth after redilution contained 0.01% oleic acid
and 1% tergitol. Additionally, 20 ml of a 1 M stock solution of MES, pH 6.0,
was added per liter medium, resulting in an initial pH of 5.7. Wild-type cells
were also precultivated the same way in this experiment. Cells were then
shifted to fresh I media containing 20 mM MES with 0.01% oleic acid and
1% tergitol or with solely 1% tergitol, as a control, and grown for 6 hr.
Acc1 activity was inhibited in vivo by adding 1 mg/ml SorA to the culture
medium where indicated: SorA is highly specific for the eukaryotic form of
acetyl-CoA carboxylase, and by its binding to the biotin carboxylase dimer
interface, it inhibits oligomerization, which is required for enzyme activity
(Shen et al., 2004).
Phenotypic Characterization
For plate tests, a single colony of the desired strains was taken from a YPD
plate and grown overnight in YPD medium (for the ole1 strain, 0.01% oleic
acid was supplemented) to reach late-logarithmic growth phase. A cell aliquot
of OD600 = 10 was harvested and washed twice with sterile water. Five micro-
liters of serial 1:10 dilutions starting with OD600 = 1/ml were spotted on to the
indicated media plates. Plates were analyzed after 2 days of growth at 30C.
To determine overproduction and excretion of inositol (Opi phenotype), a
sensitive bioassay was used (Greenberg et al., 1982): 5 ml OD600 (1 aliquot of
wild-type, tetO7ACC1, and the control strains opi1D and cho2D) were spotted
on I medium, containing the indicated concentration of doxycycline. Cells
were grown for 2 days at 30C and sprayed with a suspension of the inositol
auxotrophic (Ino) tester strain (AID), which grows as a halo only around strains
excreting inositol. Plates were analyzed after an additional 2 days of growth
at 30C.
For microscopic analysis, cultures were grown as described above and
analyzed 3 hr after the shift or in stationary phase. Labeling of neutral lipids
with BODIPY 493/503 or Nile Red was performed by adding the fluorescence
dye directly to the cell culture for 10 min at room temperature in the dark (final
concentration, 1 mg/ml). Refer to Supplemental Experimental Procedures for
detailed microscope settings.
Lipid Analysis
Cells were grown as described above, and a cell aliquot of OD600 = 20was har-
vested at the indicated time points after the media shift. Lipids were extracted
according to a slightly modified Folch method (Folch et al., 1957; Schneiter
and Daum, 2006) and analyzed on a UPLC-Synapt qTOF HDMS system
(Waters), as described by Knittelfelder et al. (2014). For total FA analysis,
an aliquot of the lipid extract was used for methyl ester production and gas
chromatography-mass spectrometry measurements. Refer to Supplemental
Experimental Procedures for lipid extraction, chromatography, and mass
spectrometry parameters.
Relative Quantification of INO1 Gene Expression
Cultureswere grown as described above and harvested 1.5 hr and 3 hr after the
shift. Real-time PCR was conducted as described elsewhere (Gaspar et al.,ors
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Acc1 Activity Regulates Gene Transcription2011). INO1 values were normalized to wild-type grown on +I media for 1.5 hr
following the shift (INO1-repressing conditions).ACT1 levels served as an inter-
nal standard for normalization. Refer to the Supplemental Experimental Proce-
dures for RNA isolation, reverse transcription, and real-time PCR parameters.
Opi1 In Vitro Binding Assays
For Opi1 binding assays, 150 ml of liposome suspension and 150 ml glutathione
S-transferase (GST)-Opi1 were incubated for 30 min at 22C and centrifuged
at 30,000 rpm for 10 min at 22C in an Optima TLX Ultracentrifuge using a
TLA-100.3 fixed angle rotor (Beckmann). Supernatants were precipitated
with 1 ml acetone at 20C overnight for nonbinding controls. Pellets were
washed once with elution buffer without glutathione, resuspended in 150 ml
elution buffer without glutathione, and precipitated with 600 ml acetone at
20C overnight. Additionally, 150 ml GST-Opi1 were precipitated with
600 ml acetone at 20C overnight as a loading control. Precipitated GST-
Opi1 protein was pelleted at 13,200 rpm for 10 min at 4C in an Eppendorf
centrifuge (Type 5415R). Pellets were washed once in 600 ml acetone and dis-
solved in protein loading buffer for SDS-PAGE. For detection of GST-Opi1
fusion protein, western blot analysis was performed using an anti-GST
antibody from goat (Sigma-Aldrich, 1:10.000) and an anti-goat antibody
conjugated with horseradish peroxidase (Pierce, 1:7.500) for detection with
SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific).
Additional experimental information in expanded form on ACC1 in vitro
mutagenesis, phospho-mass spectrometry, fluorescence microscopy, lipid
analytics, INO1 expression, Opi1 overexpression and purification, liposome
studies, and PA 32:1 synthesis is available in the Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.devcel.2014.04.025.
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